ES446895A1 - Procedimiento para preparar disoluciones parenterales de a- minoacidos. - Google Patents

Procedimiento para preparar disoluciones parenterales de a- minoacidos.

Info

Publication number
ES446895A1
ES446895A1 ES446895A ES446895A ES446895A1 ES 446895 A1 ES446895 A1 ES 446895A1 ES 446895 A ES446895 A ES 446895A ES 446895 A ES446895 A ES 446895A ES 446895 A1 ES446895 A1 ES 446895A1
Authority
ES
Spain
Prior art keywords
amino acid
solution containing
reducing sugar
parenteral solution
containing reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446895A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES446895A1 publication Critical patent/ES446895A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
ES446895A 1975-04-01 1976-04-01 Procedimiento para preparar disoluciones parenterales de a- minoacidos. Expired ES446895A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50040072A JPS51115909A (en) 1975-04-01 1975-04-01 A process for preparing amino acid parenteral injection mixed with a r educing sugar

Publications (1)

Publication Number Publication Date
ES446895A1 true ES446895A1 (es) 1977-10-01

Family

ID=12570712

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446895A Expired ES446895A1 (es) 1975-04-01 1976-04-01 Procedimiento para preparar disoluciones parenterales de a- minoacidos.

Country Status (11)

Country Link
US (1) US4085207A (es)
JP (1) JPS51115909A (es)
BE (1) BE840227A (es)
CA (1) CA1052699A (es)
CH (1) CH618849A5 (es)
DE (1) DE2614092B2 (es)
ES (1) ES446895A1 (es)
FR (1) FR2305977A1 (es)
GB (1) GB1477624A (es)
NL (1) NL184148C (es)
SE (1) SE440451B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
CA1257131A (en) * 1984-07-27 1989-07-11 John Y. Park Total parenteral and enteral nutrition composition
GB8500862D0 (en) * 1985-01-14 1985-02-20 Tate & Lyle Plc Composition
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
JPH0435507U (es) * 1990-07-20 1992-03-25
ES2264437T3 (es) * 2000-01-18 2007-01-01 Ajinomoto Co., Inc. Remedios para la hepatitis que contienen alanina y glicina.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2411897A (en) * 1943-01-02 1946-12-03 Sterling Drug Inc Pharmaceutical solution
DE1024325B (de) * 1952-10-31 1958-02-13 Colgate Palmolive Co Verfahren zum Konservieren von Lebensmitteln
US3080234A (en) * 1960-12-06 1963-03-05 Pfizer & Co C Method of improving the efficiency of amino acid diets
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition

Also Published As

Publication number Publication date
FR2305977B1 (es) 1978-09-01
DE2614092B2 (de) 1978-02-23
DE2614092A1 (de) 1976-10-14
NL7603426A (nl) 1976-10-05
NL184148B (nl) 1988-12-01
AU1247376A (en) 1977-10-06
US4085207A (en) 1978-04-18
CH618849A5 (es) 1980-08-29
FR2305977A1 (fr) 1976-10-29
SE440451B (sv) 1985-08-05
BE840227A (fr) 1976-07-16
JPS51115909A (en) 1976-10-13
GB1477624A (en) 1977-06-22
SE7603837L (sv) 1976-10-02
JPS5624647B2 (es) 1981-06-08
NL184148C (nl) 1989-05-01
CA1052699A (en) 1979-04-17

Similar Documents

Publication Publication Date Title
NL7608516A (nl) Barnsteenzuurhydrazide-eenheden bevattende copolymeren.
IE43544L (en) Ethylene-propylene-termonomer elastomers
ES451117A1 (es) Un procedimiento para preparar 3-piridil-isoxazolidinas.
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
ES446895A1 (es) Procedimiento para preparar disoluciones parenterales de a- minoacidos.
AU511736B2 (en) Enzymatically active substance
JPS51114438A (en) Reactive hot-melt adhesives
JPS5324221A (en) Frame synchronization system
JPS5282777A (en) Stable oxidase reagent solution
JPS5218888A (en) Preparation of fortimicin c
ES452943A1 (es) Procedimiento para preparar 1,2,3,4-tetrahidro-4-oxo-1-naf- tilisocianato e isotiocianato.
ZA764890B (en) Production of n,m-diethyl 2 (alpha-naphthoxy) propionamid
IE42636L (en) Diacetone-2-ketogulonic acid.
JPS5213716A (en) Multielectrode recorder
ES453883A1 (es) Un procedimiento para la preparacion de derivados sustitui- dos de 2h-piran-2, 6(3h)-diona.
AU514309B2 (en) N-acetyl thienmycin
JPS523319A (en) Crosstalk reduction system
JPS5234601A (en) Calling circuit
AU503554B2 (en) Gas diffusion electrode
JPS51141504A (en) Cyclic digital information transmission system
JPS51113551A (en) Concentrated constant-type circulator
AU494016B2 (en) Amino acid parenteral solution containing reduction sugar
IL49812A0 (en) Substituted(alpha,alpha,alpha-trifluoro-2,6-dinitro-p-tolyl)hydrazines
JPS51149712A (en) Data transmission circuit
JPS5246286A (en) Synchronization system